Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,140
Closed -$373K 127
2025
Q4
$373K Buy
+1,140
New +$362K 0.79% 41
2019
Q2
Sell
-4,382
Closed -$832K 70
2019
Q1
$832K Buy
+4,382
New +$837K 0.75% 45
2018
Q4
Sell
-2,612
Closed -$541K 60
2018
Q3
$541K Sell
2,612
-7,410
-74% -$1.46M 0.39% 57
2018
Q2
$1.85M Buy
+10,022
New +$1.77M 1.1% 29
2016
Q4
Sell
-11,470
Closed -$1.91M 99
2016
Q3
$1.91M Sell
11,470
-18,145
-61% -$3.07M 0.81% 43
2016
Q2
$4.51M Buy
29,615
+5,801
+24% +$902K 1.87% 13
2016
Q1
$3.57M Buy
23,814
+7,106
+43% +$1.06M 1.4% 25
2015
Q4
$2.71M Buy
+16,708
New +$2.63M 1.1% 28

Other funds holding AMGN

PVG Asset Management's AMGN Position: Q1 2026 in Review

PVG Asset Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 1,140 shares — an estimated $373K sold.

PVG Asset Management first reported a position in AMGN in Q4 2015 and held it in 8 quarters. The position peaked at $4.51M in Q2 2016. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • PVG Asset Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • PVG Asset Management sold 1,140 Amgen shares in Q1 2026, an estimated $373K.
  • PVG Asset Management first reported a position in Amgen in Q4 2015 and held it in 8 quarters.
  • PVG Asset Management's Amgen position peaked at $4.51M in Q2 2016.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on PVG Asset Management's 13F filing for Q1 2026, filed 16 Jun 2026.